stem cell banking market Size, Share, Trends, Growth Outlook

The global stem cell banking market Size is estimated to register 8.6% growth over the forecast period from 2023 to 2030.

 

The stem cell banking market is shaped by increasing awareness, chronic diseases, an aging population, technological advancements, regulatory support, and research and development. Cord blood banking is a significant trend, with parents opting to bank their baby's cord blood for future medical use. The debate between public and private stem cell banking is ongoing, with public banks for altruistic reasons and private banks for personalized treatments. Emerging markets are expanding stem cell banking services, and companies are forming partnerships with research institutions and healthcare providers. Services are diversifying beyond cord blood banking, and quality standards and accreditation are becoming increasingly important. Cost reduction efforts are making stem cell banking services more accessible.

 

The Surge in Chronic Diseases is creating a Demand for Stem Cell-Based Therapies, Propelling the Stem Cell Banking Market.

The escalating prevalence of chronic diseases worldwide has led to a significant surge in the demand for innovative medical treatments, spurring the growth of the stem cell banking market. Stem cell-based therapies have emerged as a promising solution for addressing a wide range of chronic ailments, including diabetes, cardiovascular diseases, and neurodegenerative disorders. These therapies harness the regenerative potential of stem cells to repair damaged tissues and organs, offering new hope to patients who previously had limited treatment options. As a result, the stem cell banking industry is experiencing robust expansion as individuals seek to preserve their own stem cells for potential future medical interventions. This trend not only reflects the increasing awareness of the therapeutic potential of stem cells but also highlights the growing importance of personalized medicine in healthcare.

 

The Growing Demand for Stem Cell Banking Services Driven by Increased Research and Development is boosting the Market.

The stem cell banking industry is experiencing a significant surge in demand, primarily propelled by a marked increase in research and development activities. Stem cell banking services have become integral in harnessing the potential of stem cells for regenerative medicine, drug development, and various therapeutic applications. Researchers and pharmaceutical companies are increasingly recognizing the versatility and promise of stem cells in treating a wide array of diseases and injuries, fuelling the demand for reliable storage and preservation solutions. This heightened interest in stem cell research has led to a growing need for specialized banks that can securely store and provide access to these valuable biological resources, contributing to the overall expansion of the stem cell banking market. As the field continues to advance, we can expect even more innovations and investments in stem cell banking services to further accelerate this market's growth.

 

Stem Cell Banking Services with Healthcare Infrastructure and Awareness Boost is creating a demand from developed and developing countries.

Stem cell banking services have witnessed demand by both developed and developing countries. This growth can be attributed to the increasing awareness surrounding the immense therapeutic potential of stem cells in treating a wide range of medical conditions. As healthcare infrastructure continues to improve globally, there is a growing realization of the importance of preserving and utilizing one's own stem cells for future medical needs. Developed countries are investing heavily in advanced stem cell banking facilities, while developing nations are catching up, recognizing the economic and medical benefits it can bring. This trend underscores the global significance of stem cell banking services as a critical component of modern healthcare infrastructure.

 

Market Share Analysis:

Placental stem cells (PSCs) stand as the predominant source of stem cells in the stem cell banking market.

garnered from the umbilical cord and placenta post-childbirth. These cells possess pluripotent properties, enabling them to differentiate into any cell type in the human body, rendering them highly valuable for regenerative medicine and various clinical applications. Their ease of collection and storage further enhances their suitability for stem cell banking. PSCs have demonstrated effectiveness in treating diverse diseases, including leukaemia, lymphoma, and sickle cell anaemia. While other stem cell sources such as adipose tissue-derived stem cells (ADSCs), bone marrow-derived stem cells (BMSCs), human embryo-derived stem cells (hESCs), and dental pulp-derived stem cells (DPSCs) are also used in stem cell banking, they are not as dominant as PSCs. These alternatives are multipotent and somewhat less versatile than PSCs and may present challenges in terms of collection and storage.

 

Sample preservation and storage is the most dominant service type in the stem cell banking market.

The domination is primarily because stem cells require ultra-low-temperature storage to maintain their viability. Stem cell banks typically provide extended storage services, spanning two to three decades, to ensure that these crucial cells remain accessible for future applications in both medical treatments and research endeavours. While other service categories like sample analysis, processing, and collection and transportation play significant roles in stem cell banking, sample preservation and storage take precedence due to their fundamental role in safeguarding stem cell longevity. In 2023, this segment is projected to maintain its dominance, reflecting the growing demand for extended stem cell storage, driven by medical and research requirements.

 

Personalized banking applications are the predominant segment in the stem cell banking market.

These applications revolve around the storage of an individual's own stem cells for potential future use in treating various diseases and conditions, including cancer, blood disorders, neurological disorders, and more. Stem cell therapy holds promise for numerous medical applications, but personalized banking stands out as it empowers individuals to safeguard their health by preserving their own stem cells. While other applications like disease treatment studies and drug discovery are vital, they do not match the dominance of personalized banking, which offers both peace of mind and the potential for improved health outcomes through personalized stem cell reserves.

 

stem cell banking Market Segmentation

By Source

• Placental Stem Cells (PSCS)
• Adipose Tissue-Derived Stem Cells (ADSCS)
• Bone Marrow-Derived Stem Cells (BMSCS)
• Human Embryo-Derived Stem Cells (HESCS)
• Dental Pulp-Derived Stem Cells (DPSCS)
• Others

 

By Service Type

• Sample Preservation and Storage
• Sample Analysis
• Sample Processing
• Sample Collection and Transportation

 

By Application

• Personalized Banking Applications
• Disease Treatment Studies
• Life Science Research
• Drug Discovery
• Hematopoietic Disorders
• Autoimmune Disorders

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

 

stem cell banking Market Companies

Leading Companies profiled in the study include-

• Cord Blood Registry (CBR) Systems (United States)
• StemCyte (United States)
• Cryo-Cell International (United States)
• Cordlife Group Limited (Singapore)
• ViaCord (United States)
• LifeCell International (India)
• Global Cord Blood Corporation (China)
• Smart Cells International (UK)
• CryoHoldco (Mexico)
• Vita34 AG (Germany)
• Cryo-Save AG (Netherlands)

 

*List not exhaustive

 

Stem cell banking Market Outlook 2023

1 Market Overview                     

1.1 Introduction to the Stem cell banking Market

1.2 Scope of the Study

1.3 Research Objective

1.3.1 Key Market Scope and Segments

1.3.2 Players Covered

1.3.3 Years Considered

 

2 Executive Summary

2.1 2023 Stem cell banking Industry- Market Statistics

3 Market Dynamics

3.1 Market Drivers

3.2 Market Challenges

3.3 Market Opportunities

3.4 Market Trends

 

4 Market Factor Analysis

4.1 Porter’s Five Forces

4.2 Market Entropy

4.2.1 Global Stem cell banking Market Companies with Area Served

4.2.2 Products Offerings Global Stem cell banking Market

 

5 COVID-19 Impact Analysis and Outlook Scenarios

5.1.1 Covid-19 Impact Analysis

5.1.2 Post-COVID-19 Scenario- Low Growth Case

5.1.3 Post-COVID-19 Scenario- Reference Growth Case

5.1.4 Post-COVID-19 Scenario- Low Growth Case

 

6 Global Stem cell banking Market Trends

6.1 Global Stem cell banking Revenue (USD Million) and CAGR (%) by Type (2018-2030)

6.2 Global Stem cell banking Revenue (USD Million) and CAGR (%) by Applications (2018-2030)

6.3 Global Stem cell banking Revenue (USD Million) and CAGR (%) by Regions (2018-2030)

 

7 Global Stem cell banking Market Revenue (USD Million) by Type, and Applications (2018-2022)

7.1 Global Stem cell banking Revenue (USD Million) by Type (2018-2022)

7.1.1 Global Stem cell banking Revenue (USD Million), Market Share (%) by Type (2018-2022)

7.2 Global Stem cell banking Revenue (USD Million) by Applications (2018-2022)

7.2.1 Global Stem cell banking Revenue (USD Million), Market Share (%) by Applications (2018-2022)

 

8 Global Stem cell banking Development Regional Status and Outlook

8.1 Global Stem cell banking Revenue (USD Million) By Regions (2018-2022)

8.2 North America Stem cell banking Revenue (USD Million) by Type, and Application (2018-2022)

8.2.1 North America Stem cell banking Revenue (USD Million) by Country (2018-2022)

8.2.2 North America Stem cell banking Revenue (USD Million) by Type (2018-2022)

8.2.3 North America Stem cell banking Revenue (USD Million) by Applications (2018-2022)

8.3 Europe Stem cell banking Revenue (USD Million), by Type, and Applications (USD Million) (2018-2022)

8.3.1 Europe Stem cell banking Revenue (USD Million), by Country (2018-2022)

8.3.2 Europe Stem cell banking Revenue (USD Million) by Type (2018-2022)

8.3.3 Europe Stem cell banking Revenue (USD Million) by Applications (2018-2022)

8.4 Asia Pacific Stem cell banking Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2018-2022)

8.4.1 Asia Pacific Stem cell banking Revenue (USD Million) by Country (2018-2022)

8.4.2 Asia Pacific Stem cell banking Revenue (USD Million) by Type (2018-2022)

8.4.3 Asia Pacific Stem cell banking Revenue (USD Million) by Applications (2018-2022)

8.5 South America Stem cell banking Revenue (USD Million), by Type, and Applications (2018-2022)

8.5.1 South America Stem cell banking Revenue (USD Million), by Country (2018-2022)

8.5.2 South America Stem cell banking Revenue (USD Million) by Type (2018-2022)

8.5.3 South America Stem cell banking Revenue (USD Million) by Applications (2018-2022)

8.6 Middle East and Africa Stem cell banking Revenue (USD Million), by Type, Technology, Application, Thickness (2018-2022)

8.6.1 Middle East and Africa Stem cell banking Revenue (USD Million) by Country (2018-2022)

8.6.2 Middle East and Africa Stem cell banking Revenue (USD Million) by Type (2018-2022)

8.6.3 Middle East and Africa Stem cell banking Revenue (USD Million) by Applications (2018-2022)

 

9 Company Profiles

 

10 Global Stem cell banking Market Revenue (USD Million), by Type, and Applications (2023-2030)

10.1 Global Stem cell banking Revenue (USD Million) and Market Share (%) by Type (2023-2030)

10.1.1 Global Stem cell banking Revenue (USD Million), and Market Share (%) by Type (2023-2030)

10.2 Global Stem cell banking Revenue (USD Million) and Market Share (%) by Applications (2023-2030)

10.2.1 Global Stem cell banking Revenue (USD Million), and Market Share (%) by Applications (2023-2030)

 

11 Global Stem cell banking Development Regional Status and Outlook Forecast

11.1 Global Stem cell banking Revenue (USD Million) By Regions (2023-2030)

11.2 North America Stem cell banking Revenue (USD Million) by Type, and Applications (2023-2030)

11.2.1 North America Stem cell banking Revenue (USD) Million by Country (2023-2030)

11.2.2 North America Stem cell banking Revenue (USD Million), by Type (2023-2030)

11.2.3 North America Stem cell banking Revenue (USD Million), Market Share (%) by Applications (2023-2030)

11.3 Europe Stem cell banking Revenue (USD Million), by Type, and Applications (2023-2030)

11.3.1 Europe Stem cell banking Revenue (USD Million), by Country (2023-2030)

11.3.2 Europe Stem cell banking Revenue (USD Million), by Type (2023-2030)

11.3.3 Europe Stem cell banking Revenue (USD Million), by Applications (2023-2030)

11.4 Asia Pacific Stem cell banking Revenue (USD Million) by Type, and Applications (2023-2030)

11.4.1 Asia Pacific Stem cell banking Revenue (USD Million), by Country (2023-2030)

11.4.2 Asia Pacific Stem cell banking Revenue (USD Million), by Type (2023-2030)

11.4.3 Asia Pacific Stem cell banking Revenue (USD Million), by Applications (2023-2030)

11.5 South America Stem cell banking Revenue (USD Million), by Type, and Applications (2023-2030)

11.5.1 South America Stem cell banking Revenue (USD Million), by Country (2023-2030)

11.5.2 South America Stem cell banking Revenue (USD Million), by Type (2023-2030)

11.5.3 South America Stem cell banking Revenue (USD Million), by Applications (2023-2030)

11.6 Middle East and Africa Stem cell banking Revenue (USD Million), by Type, and Applications (2023-2030)

11.6.1 Middle East and Africa Stem cell banking Revenue (USD Million), by Region (2023-2030)

11.6.2 Middle East and Africa Stem cell banking Revenue (USD Million), by Type (2023-2030)

11.6.3 Middle East and Africa Stem cell banking Revenue (USD Million), by Applications (2023-2030)

 

12 Methodology and Data Sources

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Sources

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Disclaimer

 

List of Tables

Table 1 Market Segmentation Analysis

Table 2 Global Stem cell banking Market Companies with Areas Served

Table 3 Products Offerings Global Stem cell banking Market

Table 4 Low Growth Scenario Forecasts

Table 5 Reference Case Growth Scenario

Table 6 High Growth Case Scenario

Table 7 Global Stem cell banking Revenue (USD Million) And CAGR (%) By Type (2018-2030)

Table 8 Global Stem cell banking Revenue (USD Million) And CAGR (%) By Applications (2018-2030)

Table 9 Global Stem cell banking Revenue (USD Million) And CAGR (%) By Regions (2018-2030)

Table 10 Global Stem cell banking Revenue (USD Million) By Type (2018-2022)

Table 11 Global Stem cell banking Revenue Market Share (%) By Type (2018-2022)

Table 12 Global Stem cell banking Revenue (USD Million) By Applications (2018-2022)

Table 13 Global Stem cell banking Revenue Market Share (%) By Applications (2018-2022)

Table 14 Global Stem cell banking Market Revenue (USD Million) By Regions (2018-2022)

Table 15 Global Stem cell banking Market Share (%) By Regions (2018-2022)

Table 16 North America Stem cell banking Revenue (USD Million) By Country (2018-2022)

Table 17 North America Stem cell banking Revenue (USD Million) By Type (2018-2022)

Table 18 North America Stem cell banking Revenue (USD Million) By Applications (2018-2022)

Table 19 Europe Stem cell banking Revenue (USD Million) By Country (2018-2022)

Table 20 Europe Stem cell banking Revenue (USD Million) By Type (2018-2022)

Table 21 Europe Stem cell banking Revenue (USD Million) By Applications (2018-2022)

Table 22 Asia Pacific Stem cell banking Revenue (USD Million) By Country (2018-2022)

Table 23 Asia Pacific Stem cell banking Revenue (USD Million) By Type (2018-2022)

Table 24 Asia Pacific Stem cell banking Revenue (USD Million) By Applications (2018-2022)

Table 25 South America Stem cell banking Revenue (USD Million) By Country (2018-2022)

Table 26 South America Stem cell banking Revenue (USD Million) By Type (2018-2022)

Table 27 South America Stem cell banking Revenue (USD Million) By Applications (2018-2022)

Table 28 Middle East and Africa Stem cell banking Revenue (USD Million) By Region (2018-2022)

Table 29 Middle East and Africa Stem cell banking Revenue (USD Million) By Type (2018-2022)

Table 30 Middle East and Africa Stem cell banking Revenue (USD Million) By Applications (2018-2022)

Table 31 Financial Analysis

Table 32 Global Stem cell banking Revenue (USD Million) By Type (2023-2030)

Table 33 Global Stem cell banking Revenue Market Share (%) By Type (2023-2030)

Table 34 Global Stem cell banking Revenue (USD Million) By Applications (2023-2030)

Table 35 Global Stem cell banking Revenue Market Share (%) By Applications (2023-2030)

Table 36 Global Stem cell banking Market Revenue (USD Million), And Revenue (USD Million) By Regions (2023-2030)

Table 37 North America Stem cell banking Revenue (USD)By Country (2023-2030)

Table 38 North America Stem cell banking Revenue (USD Million) By Type (2023-2030)

Table 39 North America Stem cell banking Revenue (USD Million) By Applications (2023-2030)

Table 40 Europe Stem cell banking Revenue (USD Million) By Country (2023-2030)

Table 41 Europe Stem cell banking Revenue (USD Million) By Type (2023-2030)

Table 42 Europe Stem cell banking Revenue (USD Million) By Applications (2023-2030)

Table 43 Asia Pacific Stem cell banking Revenue (USD Million) By Country (2023-2030)

Table 44 Asia Pacific Stem cell banking Revenue (USD Million) By Type (2023-2030)

Table 45 Asia Pacific Stem cell banking Revenue (USD Million) By Applications (2023-2030)

Table 46 South America Stem cell banking Revenue (USD Million) By Country (2023-2030)

Table 47 South America Stem cell banking Revenue (USD Million) By Type (2023-2030)

Table 48 South America Stem cell banking Revenue (USD Million) By Applications (2023-2030)

Table 49 Middle East and Africa Stem cell banking Revenue (USD Million) By Region (2023-2030)

Table 50 Middle East and Africa Stem cell banking Revenue (USD Million) By Region (2023-2030)

Table 51 Middle East and Africa Stem cell banking Revenue (USD Million) By Type (2023-2030)

Table 52 Middle East and Africa Stem cell banking Revenue (USD Million) By Applications (2023-2030)

Table 53 Research Programs/Design for This Report

Table 54 Key Data Information from Secondary Sources

Table 55 Key Data Information from Primary Sources

 

List of Figures

Figure 1 Market Scope

Figure 2 Porter’s Five Forces

Figure 3 Global Stem cell banking Revenue (USD Million) By Type (2018-2022)

Figure 4 Global Stem cell banking Revenue Market Share (%) By Type (2022)

Figure 5 Global Stem cell banking Revenue (USD Million) By Applications (2018-2022)

Figure 6 Global Stem cell banking Revenue Market Share (%) By Applications (2022)

Figure 7 Global Stem cell banking Market Revenue (USD Million) By Regions (2018-2022)

Figure 8 Global Stem cell banking Market Share (%) By Regions (2022)

Figure 9 North America Stem cell banking Revenue (USD Million) By Country (2018-2022)

Figure 10 North America Stem cell banking Revenue (USD Million) By Type (2018-2022)

Figure 11 North America Stem cell banking Revenue (USD Million) By Applications (2018-2022)

Figure 12 Europe Stem cell banking Revenue (USD Million) By Country (2018-2022)

Figure 13 Europe Stem cell banking Revenue (USD Million) By Type (2018-2022)

Figure 14 Europe Stem cell banking Revenue (USD Million) By Applications (2018-2022)

Figure 15 Asia Pacific Stem cell banking Revenue (USD Million) By Country (2018-2022)

Figure 16 Asia Pacific Stem cell banking Revenue (USD Million) By Type (2018-2022)

Figure 17 Asia Pacific Stem cell banking Revenue (USD Million) By Applications (2018-2022)

Figure 18 South America Stem cell banking Revenue (USD Million) By Country (2018-2022)

Figure 19 South America Stem cell banking Revenue (USD Million) By Type (2018-2022)

Figure 20 South America Stem cell banking Revenue (USD Million) By Applications (2018-2022)

Figure 21 Middle East and Africa Stem cell banking Revenue (USD Million) By Region (2018-2022)

Figure 22 Middle East and Africa Stem cell banking Revenue (USD Million) By Type (2018-2022)

Figure 23 Middle East and Africa Stem cell banking Revenue (USD Million) By Applications (2018-2022)

Figure 24 Global Stem cell banking Revenue (USD Million) By Type (2023-2030)

Figure 25 Global Stem cell banking Revenue Market Share (%) By Type (2030)

Figure 26 Global Stem cell banking Revenue (USD Million) By Applications (2023-2030)

Figure 27 Global Stem cell banking Revenue Market Share (%) By Applications (2030)

Figure 28 Global Stem cell banking Market Revenue (USD Million) By Regions (2023-2030)

Figure 29 North America Stem cell banking Revenue (USD Million) By Country (2023-2030)

Figure 30 North America Stem cell banking Revenue (USD Million) By Type (2023-2030)

Figure 31 North America Stem cell banking Revenue (USD Million) By Applications (2023-2030)

Figure 32 Europe Stem cell banking Revenue (USD Million) By Country (2023-2030)

Figure 33 Europe Stem cell banking Revenue (USD Million) By Type (2023-2030)

Figure 34 Europe Stem cell banking Revenue (USD Million) By Applications (2023-2030)

Figure 35 Asia Pacific Stem cell banking Revenue (USD Million) By Country (2023-2030)

Figure 36 Asia Pacific Stem cell banking Revenue (USD Million) By Type (2023-2030)

Figure 37 Asia Pacific Stem cell banking Revenue (USD Million) By Applications (2023-2030)

Figure 38 South America Stem cell banking Revenue (USD Million) By Country (2023-2030)

Figure 39 South America Stem cell banking Revenue (USD Million) By Type (2023-2030)

Figure 40 South America Stem cell banking Revenue (USD Million) By Applications (2023-2030)

Figure 41 Middle East and Africa Stem cell banking Revenue (USD Million) By Region (2023-2030)

Figure 42 Middle East and Africa Stem cell banking Revenue (USD Million) By Region (2023-2030)

Figure 43 Middle East and Africa Stem cell banking Revenue (USD Million) By Type (2023-2030)

Figure 44 Middle East and Africa Stem cell banking Revenue (USD Million) By Applications (2023-2030)

Figure 45 Bottom-Up and Top-Down Approaches For This Report

Figure 46 Data Triangulation

 

stem cell banking Market Segmentation

By Source

• Placental Stem Cells (PSCS)
• Adipose Tissue-Derived Stem Cells (ADSCS)
• Bone Marrow-Derived Stem Cells (BMSCS)
• Human Embryo-Derived Stem Cells (HESCS)
• Dental Pulp-Derived Stem Cells (DPSCS)
• Others

 

By Service Type

• Sample Preservation and Storage
• Sample Analysis
• Sample Processing
• Sample Collection and Transportation

 

By Application

• Personalized Banking Applications
• Disease Treatment Studies
• Life Science Research
• Drug Discovery
• Hematopoietic Disorders
• Autoimmune Disorders

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)